Kymera TherapeuticsKYMR
那斯達克 · USD
44.20
-1.59
(-3.47%)
收盤 07/29 03:59 (UTC+8)
盤後
0
0
(0%)
07/29 03:59 (UTC+8)
Kymera TherapeuticsKYMR
44.20
-1.59
(-3.47%)
財務數據
損益表
- 0.16
- 0.09
- 0.17
- 0.05
- 0.48
- 0.10
- 0.26
- 0.04
- 0.07
- 0.22
- 68.98
- -41.35
- 74.45
- -71.37
- 912.80
- -78.52
- 149.34
- -85.42
- 97.65
- 198.89
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 22,100 | 7,394 | 3,741 | 25,650 | 10,287 | 47,885 | 4,728 | 16,513 | 9,466 | 16,139 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 22,100 | 7,394 | 3,741 | 25,650 | 10,287 | 47,885 | 4,728 | 16,513 | 9,466 | 16,139 |
營業費用 | 96,526 | 88,149 | 75,865 | 76,575 | 68,118 | 67,197 | 62,237 | 59,896 | 54,792 | 54,769 |
研發費用 | 80,255 | 71,817 | 60,410 | 59,202 | 48,819 | 52,970 | 48,117 | 45,767 | 42,227 | 43,133 |
推銷及管理費用 | 16,271 | 16,332 | 15,455 | 17,373 | 14,374 | 14,227 | 14,120 | 14,129 | 12,565 | 11,636 |
非經常性項目費用 | - | - | - | - | 4,925 | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -74,426 | -80,755 | -72,124 | -50,925 | -57,831 | -19,312 | -57,509 | -43,383 | -45,326 | -38,630 |
其他收入及費用 | 8,917 | 10,062 | 9,696 | 8,925 | 9,343 | 4,996 | 4,683 | 4,632 | 4,453 | 3,824 |
利息費用 | 72 | 59 | 59 | 62 | 69 | 52 | 41 | 48 | 55 | 59 |
稅前純益 | -65,581 | -70,752 | -62,487 | -42,062 | -48,557 | -14,368 | -52,867 | -38,799 | -40,928 | -34,865 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -65,581 | -70,752 | -62,487 | -42,062 | -48,557 | -14,368 | -52,867 | -38,799 | -40,928 | -34,865 |
基本每股稅後盈餘(元) | -0.82 | -0.88 | -0.82 | -0.58 | -0.69 | -0.25 | -0.90 | -0.67 | -0.70 | -0.60 |
稀釋每股稅後盈餘(元) | -0.82 | -0.89 | -0.83 | -0.57 | -0.69 | -0.25 | -0.90 | -0.67 | -0.70 | -0.59 |
基本平均股數(千股) | 80146.00 | 79987.00 | 76125.00 | 73059.00 | 70770.00 | 58521.00 | 58421.00 | 58326.00 | 58187.00 | 57889.00 |
稀釋平均股數(千股) | 80146.00 | 79987.00 | 76125.00 | 73059.00 | 70770.00 | 58521.00 | 58421.00 | 58326.00 | 58187.00 | 57889.00 |
還原基本每股稅後盈餘(元) | -0.82 | -0.88 | -0.82 | -0.58 | -0.69 | -0.25 | -0.90 | -0.67 | -0.70 | -0.60 |
還原稀釋每股稅後盈餘(元) | -0.82 | -0.89 | -0.83 | -0.57 | -0.69 | -0.25 | -0.90 | -0.67 | -0.70 | -0.59 |
還原基本平均股數(千股) | 80,146 | 79,987 | 76,125 | 73,059 | 70,770 | 58,521 | 58,421 | 58,326 | 58,187 | 57,889 |
還原稀釋平均股數(千股) | 80,146 | 79,987 | 76,125 | 73,059 | 70,770 | 58,521 | 58,421 | 58,326 | 58,187 | 57,889 |
EBITDA(千元) | -63,461 | -68,706 | -60,441 | -40,062 | -47,027 | -13,425 | -51,931 | -37,851 | -39,994 | -33,988 |